Mirae Asset Global Investments Co., Ltd.

Position in PRME — Prime Medicine, Inc.

CIK 1569395 SEOUL, M5

Position in PRME

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$29,807

-$2,957 QoQ

Shares Held

8,078

-14.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#150

of 186 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. PRME ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,807	8,078	-14.2%	Shares	Sole	2026-07-22
2026-03-31	$32,764	9,415	+7.3%	Shares	Sole	2026-05-04
2025-12-31	$30,438	8,772	+29.8%	Shares	Sole	2026-01-26
2025-09-30	$37,450	6,760	+33.3%	Shares	Sole	2025-11-03
2025-06-30	$12,527	5,072	+15.6%	Shares	Sole	2025-07-21
2025-03-31	$8,734	4,389	+0.4%	Shares	Sole	2025-04-24
2024-12-31	$12,763	4,371	+0.7%	Shares	Sole	2025-01-27
2024-09-30	$16,799	4,341	+21.1%	Shares	Sole	2024-10-23
2024-06-30	$18,421	3,584	-83.2%	Shares	Sole	2024-07-30
2023-12-31	$188,726	21,301	-7.5%	Shares	Defined	2024-01-24
2023-09-30	$219,572	23,016	+22.0%	Shares	Defined	2023-10-26
2023-06-30	$276,460	18,871	—	Shares	Defined	2023-08-10
No filing history on record for this holder in this stock.